{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:15:34Z","timestamp":1778681734655,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1038301"],"award-info":[{"award-number":["OPP1038301"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1112376"],"award-info":[{"award-number":["OPP1112376"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.vaccine.2019.02.060","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T16:45:25Z","timestamp":1564159525000},"page":"4800-4804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Technical product attributes in development of an oral enteric vaccine for infants"],"prefix":"10.1016","volume":"37","author":[{"given":"Jessica A.","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3574-9989","authenticated-orcid":false,"given":"Manjari","family":"Lal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vaccine.2019.02.060_b0005","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.vaccine.2018.01.011","article-title":"Cost of goods sold and total cost of delivery for oral and parenteral vaccine packaging formats","volume":"36","author":"Sedita","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.060_b0010","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1586\/14760584.4.6.807","article-title":"New vaccines against enteric bacteria for children in less developed countries","volume":"4","author":"Walker","year":"2005","journal-title":"Exp Rev Vaccines"},{"issue":"46\u201347","key":"10.1016\/j.vaccine.2019.02.060_b0015","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1016\/j.vaccine.2005.01.161","article-title":"Enteric vaccines for pediatric use. Workshop summary","volume":"23","author":"Walker","year":"2005","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.vaccine.2019.02.060_b0020","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/j.vaccine.2004.12.029","article-title":"Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries","volume":"23","author":"Walker","year":"2005","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2019.02.060_b0025","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.vaccine.2014.11.049","article-title":"An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children","volume":"33","author":"Walker","year":"2015","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2019.02.060_b0030","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1080\/21645515.2018.1461296","article-title":"Noninvasive vaccination against infectious diseases","volume":"14","author":"Zheng","year":"2018","journal-title":"Hum Vaccin Immunother."},{"issue":"49 Pt A","key":"10.1016\/j.vaccine.2019.02.060_b0035","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1016\/j.vaccine.2017.07.036","article-title":"Global burden of diarrheal diseases among children in developing countries: Incidence, etiology, and insights from new molecular diagnostic techniques","volume":"35","author":"Kotloff","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2019.02.060_b0040","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.pcl.2017.03.006","article-title":"The burden and etiology of diarrheal illness in developing countries","volume":"64","author":"Kotloff","year":"2017","journal-title":"Pediatr Clin North Am"},{"issue":"26","key":"10.1016\/j.vaccine.2019.02.060_b0045","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.vaccine.2016.02.075","article-title":"Status of vaccine research and development for Shigella","volume":"34","author":"Mani","year":"2016","journal-title":"Vaccine"},{"issue":"49 Pt A","key":"10.1016\/j.vaccine.2019.02.060_b0050","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.1016\/j.vaccine.2017.09.045","article-title":"Vaccines against Shigella and enterotoxigenic Escherichia coli: s summary of the 2016 VASE Conference","volume":"35","author":"Walker","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.060_b0055","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vaccine.2011.11.003","article-title":"New insights in mucosal vaccine development","volume":"30","author":"Pavot","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.060_b0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jim.2017.09.003","article-title":"Preformulation studies with the Escherichia coli double mutant heat-labile toxin adjuvant for use in an oral vaccine","volume":"451","author":"White","year":"2017","journal-title":"J Immunol Methods"},{"issue":"46","key":"10.1016\/j.vaccine.2019.02.060_b0065","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.1016\/j.vaccine.2015.09.063","article-title":"A study of different buffers to maximize viability of an oral Shigella vaccine","volume":"33","author":"Chandrasekaran","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.060_b0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/21645515.2016.1238536","article-title":"Presentation matters: buffers, packaging, and delivery devices for new, oral enteric vaccines for infants","volume":"13","author":"Lal","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"22","key":"10.1016\/j.vaccine.2019.02.060_b0075","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1016\/j.vaccine.2016.03.093","article-title":"Stability of live attenuated rotavirus vaccine with selected preservatives and primary containers","volume":"34","author":"Lal","year":"2016","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.060_b0080","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/erv.09.20","article-title":"Opportunities and challenges of developing thermostable vaccines","volume":"8","author":"Chen","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.060_b0085","doi-asserted-by":"crossref","first-page":"11618","DOI":"10.4161\/hv.6.3.11618","article-title":"Stabilization of vaccines: lessons learned","volume":"6","author":"Kristensen","year":"2010","journal-title":"Hum Vaccine"},{"issue":"41","key":"10.1016\/j.vaccine.2019.02.060_b0090","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.1016\/j.vaccine.2011.05.070","article-title":"Vaccine stabilization: research, commercialization, and potential impact","volume":"29","author":"Kristensen","year":"2011","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2019.02.060_b0095","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1080\/21645515.2018.1487499","article-title":"Rational design of heat stable lyophilized rotavirus vaccine formulations","volume":"14","author":"Madan","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"22","key":"10.1016\/j.vaccine.2019.02.060_b0100","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/j.vaccine.2017.04.025","article-title":"Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL\u00ae)","volume":"35","author":"Naik","year":"2017","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2019.02.060_b0105","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1586\/erv.12.101","article-title":"Spray drying and vaccine stabilization","volume":"11","author":"McAdams","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.060_b0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2471\/BLT.12.110700","article-title":"Vaccine presentation and packaging advisory group: a forum for reaching consensus on vaccine product attributes","volume":"91","author":"Mansoor","year":"2013","journal-title":"Bull World Health Organ"},{"issue":"17","key":"10.1016\/j.vaccine.2019.02.060_b0115","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.vaccine.2016.11.095","article-title":"Exploring new packaging and delivery options for the immunization supply chain","volume":"35","author":"Zehrung","year":"2017","journal-title":"Vaccine"},{"issue":"49 Pt A","key":"10.1016\/j.vaccine.2019.02.060_b0120","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1016\/j.vaccine.2017.04.063","article-title":"Challenges of vaccine presentation and delivery: How can we design vaccines to have optimal programmatic impact?","volume":"35","author":"Giersing","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.060_b0125","doi-asserted-by":"crossref","first-page":"e2629","DOI":"10.1371\/journal.pntd.0002629","article-title":"Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model","volume":"8","author":"Kar","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.060_b0130","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.vaccine.2012.11.012","article-title":"Immune responses and protection in children in developing countries induced by oral vaccines","volume":"31","author":"Qadri","year":"2013","journal-title":"Vaccine"},{"issue":"42","key":"10.1016\/j.vaccine.2019.02.060_b0135","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1016\/j.vaccine.2013.08.010","article-title":"Development of a fast-dissolving tablet formulation of a live attenuated enterotoxigenic E. coli vaccine candidate","volume":"31","author":"Lal","year":"2013","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2019.02.060_b0140","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.vaccine.2016.08.045","article-title":"Improving cold chain systems: challenges and solutions","volume":"35","author":"Ashok","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.060_b0145","unstructured":"World Health Organization (WHO). 2012. Assessing the programmatic suitability of vaccine candidates for WHO prequalification. WHO\/IVB\/12.10. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/148168\/WHO_IVB_14.10_eng.pdf;jsessionid=840A863738903AA841F79E381ABDABCA?sequence=1 [accessed 25 January, 2019]."},{"key":"10.1016\/j.vaccine.2019.02.060_b0150","unstructured":"Giersing B. Update on Immunization Practices Advisory Committee (IPAC): WHO Product Development for Vaccines Advisory Committee (PDVAC) meeting \u2013 2016. http:\/\/www.who.int\/immunization\/research\/meetings_workshops\/7._The_IPAC_delivery_technologies_working_group.pdf?ua=1; 2016 [accessed 20 November 2018]."},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.060_b0155","first-page":"549","article-title":"Nasal congestion in infants and children: a literature review on efficacy and safety of non-pharmacological treatments","volume":"66","author":"Chirico","year":"2014","journal-title":"MinervaPediatr"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.060_b0160","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4161\/hv.19568","article-title":"The mucosal vaccine quandary: intranasal vs. sublingual immunization against influenza","volume":"8","author":"Pedersen","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.02.060_b0165","unstructured":"Gavi, The Vaccine Alliance. Oral cholera vaccine support, https:\/\/www.gavi.org\/support\/nvs\/cholera-vaccine\/ [accessed 25 January, 2019]."},{"issue":"45","key":"10.1016\/j.vaccine.2019.02.060_b0170","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1016\/j.vaccine.2018.09.026","article-title":"The euvichol story \u2013 development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships","volume":"36","author":"Odevall","year":"2018","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:31:26Z","timestamp":1778679086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19302671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":34,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0264410X19302671"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Technical product attributes in development of an oral enteric vaccine for infants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}